Weiner, et al., “Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens”, Annu Rev Immunol 1994;12:809-837. |
Trentham, et al., “Autoimmunity to Type II Collagen: An Experimental Model of Arthritis”, J Exp Med 1977;146:857-868. |
Courtenay, et al., “Immunization Against Heterologous Type II Collagen Induced Arthritis in Mice”, Nature 1980;283-665. |
Nagler-Anderson, et al., “Suppression of the Type II Collagen-Induced Arthritis by Intragastric Administration of Soluble Type II Collagen”, Proc Natl Acad Sci USA 1986;83:7443-7446. |
Thompson, et al., “Suppression of CIA by Oral Administration of Type II Collagen: Changes in Immune and Arthritic Responses Mediated by Active Peripheral Suppression”, Autoimmunity 1993;16:189-199. |
Zhand, et al., “Suppression of Adjuvant Arthritis in Lewis Rats by Oral Administration of Type II Collagen”, J Immunol 1990;145:2489-2493. |
Paroli, et al., “A Pharmacological Approach to Glycosaminoglycans”, Drugs Expth Clin Res VII (1) Sep. 9-20, 1991. |
Miller, et al., “Characterization of Notochord Collagen”, Biochemical and Biophysical Research Communications, vol. 60, No. 1, 1974. |
Matthews, “Comparative Biochemistry of Chondroitin Sulphate-Proteins of Cartilage and Notochord”, Biochem J., 1971, 125, 37-46. |